Innovating Works

IRBM

Desconocido
RE-STORE: Pharmacological restoration of selective autophagy for the treatment of skeletal disorders IRBM SPA participó en un H2020: ERC-2020-PoC Lysosomal storage disorders (LSDs) are a family of inherited genetic diseases characterized by lysosomal dysfunction, with a consequent bloc...
2020-12-12 - 2022-06-30 | Financiado
Halo: Development and Application of a New Class of Halogenated Reagents to Commercially Valuable Targets IRBM SPA participó en un H2020: H2020-MSCA-RISE-2016 The aim of this project is to expand upon a newly discovered platform reaction by developing new routes to Active Pharmaceutical Ingredients...
2016-12-14 - 2020-12-31 | Financiado
MAGICBULLET: Peptide Drug Conjugates for Targeted Delivery in Tumor Therapy IRBM SPA participó en un H2020: H2020-MSCA-ITN-2014 Many tumor cells are characterized by the overexpression of certain antigens. Molecules that specifically recognize these structures are sui...
2014-12-05 - 2018-12-31 | Financiado
CARESS: A new methodology based on an advanced molecular probe for early detection of DPD enzyme deficiency... IRBM SPA tramitó un FP7: "Amongst all the chemotherapy agents, 5-FU (fluorouracil) is being in use since 40 years, and is one of the most successful and widely emplo...
Financiado
EU-OPENSCREEN: European Infrastructure of Open Screening Platforms for Chemical Biology IRBM SPA participó en un FP7: The EU-OPENSCREEN Preparatory Phase forms the basis for the construction and operation of a pan-European infrastructure of open screening pl...
Financiado
THINPAD: Targeting the HIV 1 Nucleocapsid Protein to fight Antiretroviral Drug Resistance IRBM SPA participó en un FP7: AIDS is one of the most serious pandemic diseases of the modern era. Although current therapies based on targeting key processes of the HIV...
Financiado
AQUALITY: On line industrial water quality analysis system for rapid and accurate detection of pathogens IRBM SPA participó en un FP7: "Currently the identification and quantification of pollutants in water are mostly carried out manually through sampling and subsequent labo...
Financiado
THALAMOSS: THALAssaemia MOdular Stratification System for personalized therapy of beta thalassemia IRBM SPA participó en un FP7: THALAMOSS is aimed at development of universal sets of markers and techniques for stratification of β-thalassaemia patients into treatment s...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.